Relatively little is known about reproductive decision-making in women harboring mutations in the BRCA1 and/or BRCA2—pathogenic variants that confer different cancer risk profiles and underlie hereditary breast and ovarian cancer. The gene discussed is BRCA1; the disease is ovarian cancer.